Guru Ownership Trend
Guru Analysis for Cytokinetics, Incorporated (CYTK)
Cytokinetics, Incorporated (CYTK), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $93.34 M.
Top institutional holders include Ken Fisher and Cliff Asness.
Institutional sentiment is currently Bearish. This is evidenced by a $50.78 M net outflow during the quarter.
Recent activity highlights Chuck Royce who increased their stake by 44.3%. Conversely, Cliff Asness reduced exposure by 53.8%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Cytokinetics, Incorporated (CYTK)
Major holders include Ken Fisher ($52.29 M), Cliff Asness ($14.77 M), Renaissance Technologies (RenTech) ($10.93 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.4 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $50.78 M, with 2 managers increasing positions and 4 managers reducing holdings.
During the most recent reporting period, 2 managers trimmed their positions, while 2 fully exited CYTK. The total reported sell value was $57.49 M.
Yes, 0 managers opened new positions in CYTK, and 2 increased their existing holdings. The total reported buy value was $6.71 M.